Related Experiment Video

Updated: Jun 15, 2026

Clinical Application of Phase Angle and BIVA Z-Score Analyses in Patients Admitted to an Emergency Department with Acute Heart Failure
04:05

Clinical Application of Phase Angle and BIVA Z-Score Analyses in Patients Admitted to an Emergency Department with Acute Heart Failure

Published on: June 30, 2023

Risk stratification of ventricular arrhythmias in patients with systolic heart failure

Richard N Vest1, Michael R Gold

  • 1Division of Cardiology, Medical University of South Carolina, Charleston, South Carolina 29425, USA. rvest@musc.edu

Current Opinion in Cardiology
|March 13, 2010
PubMed

Insights

Sudden cardiac death (SCD) remains a significant concern, with implantable cardioverter defibrillators (ICDs) offering prevention. However, current risk stratification for ICD therapy in heart failure patients needs improvement for better patient selection.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Sudden Cardiac Death Research

Background:

  • Sudden cardiac death (SCD) causes a substantial number of deaths annually in the US.
  • Implantable cardioverter defibrillators (ICDs) are crucial for SCD prevention in heart failure patients.
  • Current patient selection for ICDs relies heavily on ejection fraction and heart failure status, necessitating improved risk stratification.

Purpose of the Study:

  • To review current methods for risk stratification in patients undergoing implantable cardioverter defibrillator (ICD) implantation.
  • To evaluate the effectiveness of various tools in predicting ventricular arrhythmias and guiding ICD therapy.
  • To identify the need for enhanced risk stratification beyond traditional markers.

Main Methods:

  • Review of multicenter studies and clinical data.
  • Evaluation of risk stratification tools including microvolt T-wave alternans, resting ECG, nonsustained ventricular tachycardia, autonomic function tests, and cardiac MRI.
  • Analysis of predictive value and clinical applicability of different risk assessment methods.

Main Results:

  • Microvolt T-wave alternans has not been confirmed as a reliable predictor of ventricular arrhythmias in patients with ICDs.
  • While resting ECG, nonsustained ventricular tachycardia, autonomic function tests, and cardiac MRI show predictive value, their clinical applicability is currently limited.
  • Depressed ejection fraction with symptomatic heart failure remains the strongest predictor of SCD.

Conclusions:

  • Current patient selection for ICDs primarily relies on depressed ejection fraction and symptomatic heart failure.
  • No single test or combination of tests definitively predicts arrhythmic events for optimal ICD therapy.
  • Continued research into additional risk factors and refined risk stratification tools is essential for improving SCD prevention.
Abstract

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...